biliary tract disease

Literature (4)

Literature for DOID 9741: biliary tract disease

Xenbase Articles Publications associated with this Disease Ontology entry or its descendants

:
(

Denotes literature images)

Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies., Ghibellini G,Leslie EM,Pollack GM,Brouwer KL, Pharm Res. August 1, 2008; 25(8):1573-904X.
A homozygous nonsense mutation (c.214C->A) in the biliverdin reductase alpha gene (BLVRA) results in accumulation of biliverdin during episodes of cholestasis., Nytofte NS,Serrano MA,Monte MJ,Gonzalez-Sanchez E,Tumer Z,Ladefoged K,Briz O,Marin JJ, J Med Genet. April 1, 2011; 48(4):1468-6244.
The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice., Lieu T,Jayaweera G,Zhao P,Poole DP,Jensen D,Grace M,McIntyre P,Bron R,Wilson YM,Krappitz M,Haerteis S,Korbmacher C,Steinhoff MS,Nassini R,Materazzi S,Geppetti P,Corvera CU,Bunnett NW, Gastroenterology. December 1, 2014; 147(6):1528-0012.
TPX2 level correlates with cholangiocarcinoma cell proliferation, apoptosis, and EMT., Zou Z,Zheng B,Li J,Lv X,Zhang H,Yu F,Kong L,Li Y,Yu M,Fang L,Liang B, Biomed Pharmacother. November 1, 2018; 107:0753-3322.

Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies., Ghibellini G,Leslie EM,Pollack GM,Brouwer KL, Pharm Res. August 1, 2008; 25(8):1573-904X.

A homozygous nonsense mutation (c.214C->A) in the biliverdin reductase alpha gene (BLVRA) results in accumulation of biliverdin during episodes of cholestasis., Nytofte NS,Serrano MA,Monte MJ,Gonzalez-Sanchez E,Tumer Z,Ladefoged K,Briz O,Marin JJ, J Med Genet. April 1, 2011; 48(4):1468-6244.

The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice., Lieu T,Jayaweera G,Zhao P,Poole DP,Jensen D,Grace M,McIntyre P,Bron R,Wilson YM,Krappitz M,Haerteis S,Korbmacher C,Steinhoff MS,Nassini R,Materazzi S,Geppetti P,Corvera CU,Bunnett NW, Gastroenterology. December 1, 2014; 147(6):1528-0012.

TPX2 level correlates with cholangiocarcinoma cell proliferation, apoptosis, and EMT., Zou Z,Zheng B,Li J,Lv X,Zhang H,Yu F,Kong L,Li Y,Yu M,Fang L,Liang B, Biomed Pharmacother. November 1, 2018; 107:0753-3322.